Susquehanna International Group, LLP Humacyte, Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$5.11 - $9.46 $732,263 - $1.36 Million	143,300 Added 108.48%	275,400 $1.5 Million
Q2 2024 Aug 15, 2024	BUY	$2.87 - $9.1 $80,934 - $256,620	28,200 Added 27.14%	132,100 $634,000
Q1 2024 May 07, 2024	BUY	$2.57 - $4.84 $231,814 - $436,568	90,200 Added 658.39%	103,900 $323,000
Q4 2023 Feb 14, 2024	SELL	$1.99 - $3.12 $17,711 - $27,768	-8,900 Reduced 39.38%	13,700 $38,000
Q3 2023 Nov 14, 2023	BUY	$2.75 - $4.48 $62,150 - $101,248	22,600 New	22,600 $66,000
Q3 2022 Nov 14, 2022	SELL	$1.22 - $5.14 $8,662 - $36,494	-7,100 Reduced 7.8%	83,900 $274,000

150

35.1M

279K

607K

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $499M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.